Retro Biosciences is set to run a clinical trial for an aging drug designed to reverse Alzheimer's, its CEO Joe Betts-LaCroix ...

NeuroNOS, a biopharmaceutical company focused on developing treatments for neurological disorders and neuro-oncology, and a subsidiary of Beyond Air (NASDAQ: XAIR), today announced that the U.S. Food ...

Nkanginieme makes his argument for the benefits of adding a Biochemistry major to the University’s catalogue. Not a month passes in which I don’t wish Hopkins offered a Bachelor of Science in ...

By Sophie Lange, Managing Editor President Bob Iuliano opened Thursday’s faculty meeting by acknowledging the 24th ...